146 related articles for article (PubMed ID: 32767666)
21. A randomised controlled feasibility trial to evaluate Lawsonia inermis (henna)'s effect on palmar-plantar erythrodysesthesia induced by capecitabine or pegylated liposomal doxorubicin.
Stavrinou M; Tsitsi T; Astras G; Paikousis L; Charalambous A
Eur J Oncol Nurs; 2021 Apr; 51():101908. PubMed ID: 33626423
[TBL] [Abstract][Full Text] [Related]
22. Acral erythema in children receiving high-dose methotrexate.
Millot F; Auriol F; Brecheteau P; Guilhot F
Pediatr Dermatol; 1999; 16(5):398-400. PubMed ID: 10571844
[TBL] [Abstract][Full Text] [Related]
23. Pyridoxine therapy for palmar-plantar erythrodysesthesia associated with continuous 5-fluorouracil infusion.
Fabian CJ; Molina R; Slavik M; Dahlberg S; Giri S; Stephens R
Invest New Drugs; 1990 Feb; 8(1):57-63. PubMed ID: 2345070
[TBL] [Abstract][Full Text] [Related]
24. [Breast cancer and the hand-foot syndrome].
Llambrich C; Falcou MC; De Rycke Y; Cottu P; Carrié S; Medjbari M
Soins; 2012 Jun; (766):25-8. PubMed ID: 22870762
[TBL] [Abstract][Full Text] [Related]
25. Fatal palmar-plantar erythrodysesthesia after clofarabine and cytarabine chemotherapy.
Hwang YY; Trendell-Smith NJ; Yeung CK; Kwong YL
Acta Haematol; 2012; 128(3):151-3. PubMed ID: 22890199
[No Abstract] [Full Text] [Related]
26. Prevention of palmoplantar erythrodysesthesia in patients treated with pegylated liposomal doxorubicin (Caelyx®).
Jung S; Sehouli J; Chekerov R; Kluschke F; Patzelt A; Fuss H; Knorr F; Lademann J
Support Care Cancer; 2017 Nov; 25(11):3545-3549. PubMed ID: 28653108
[TBL] [Abstract][Full Text] [Related]
27. Chemotherapy-induced hand-foot syndrome and nail changes: a review of clinical presentation, etiology, pathogenesis, and management.
Miller KK; Gorcey L; McLellan BN
J Am Acad Dermatol; 2014 Oct; 71(4):787-94. PubMed ID: 24795111
[TBL] [Abstract][Full Text] [Related]
28. Palmar-plantar Erythrodysesthesia with Genital Involvement Secondary to Capecitabine Chemoradiotherapy: A Case Report.
Hu HP; Corkum MT; Perera F
Cureus; 2018 Dec; 10(12):e3704. PubMed ID: 30788193
[TBL] [Abstract][Full Text] [Related]
29. Palmar-plantar erythrodysesthesia secondary to docetaxel chemotherapy: a case report.
Benghiat H; Al-Niaimi A
J Med Case Rep; 2011 Feb; 5():80. PubMed ID: 21352522
[TBL] [Abstract][Full Text] [Related]
30. Erythrodysesthesia: An Unusual Complication With Trastuzumab Monotherapy.
Fontenot AL; Furr WJ; Husan A; Khan MW
Cureus; 2021 Nov; 13(11):e20060. PubMed ID: 34993032
[TBL] [Abstract][Full Text] [Related]
31. Pegylated liposomal doxorubicin-related palmar-plantar erythrodysesthesia ('hand-foot' syndrome).
Lorusso D; Di Stefano A; Carone V; Fagotti A; Pisconti S; Scambia G
Ann Oncol; 2007 Jul; 18(7):1159-64. PubMed ID: 17229768
[TBL] [Abstract][Full Text] [Related]
32. Regorafenib-associated hand-foot skin reaction: practical advice on diagnosis, prevention, and management.
McLellan B; Ciardiello F; Lacouture ME; Segaert S; Van Cutsem E
Ann Oncol; 2015 Oct; 26(10):2017-26. PubMed ID: 26034039
[TBL] [Abstract][Full Text] [Related]
33. Intrathecal methotrexate overdose.
Lee AC; Wong KW; Fong KW; So KT
Acta Paediatr; 1997 Apr; 86(4):434-7. PubMed ID: 9174236
[TBL] [Abstract][Full Text] [Related]
34. Unusual scrotal and penile ulcerations together with palmar-plantar erythrodysesthesia syndrome in a patient with metastatic colon carcinoma treated with capecitabine.
Ljubojevic Hadzavdic S; Stulhofer Buzina D; Murtezani I; Skerlev M
J Eur Acad Dermatol Venereol; 2017 Jun; 31(6):e304-e306. PubMed ID: 27987319
[No Abstract] [Full Text] [Related]
35. Efficient prevention strategy against the development of a palmar-plantar erythrodysesthesia during chemotherapy.
Lademann J; Martschick A; Kluschke F; Richter H; Fluhr JW; Patzelt A; Jung S; Chekerov R; Darvin ME; Haas N; Sterry W; Zastrow L; Sehouli J
Skin Pharmacol Physiol; 2014; 27(2):66-70. PubMed ID: 23969763
[TBL] [Abstract][Full Text] [Related]
36. Randomized trial of two different doses of pyridoxine in the prevention of capecitabine-associated palmar-plantar erythrodysesthesia.
Chalermchai T; Tantiphlachiva K; Suwanrusme H; Voravud N; Sriuranpong V
Asia Pac J Clin Oncol; 2010 Sep; 6(3):155-60. PubMed ID: 20887495
[TBL] [Abstract][Full Text] [Related]
37. Bullous variant of acral erythema in a child after high-dose methotrexate.
Zils K; Wilhelm M; Reeh T; Bielack S
Pediatr Hematol Oncol; 2012 May; 29(4):378-9. PubMed ID: 22568802
[No Abstract] [Full Text] [Related]
38. Rituximab with chemotherapy in children and adolescents with central nervous system and/or bone marrow-positive Burkitt lymphoma/leukaemia: a Children's Oncology Group Report.
Goldman S; Smith L; Galardy P; Perkins SL; Frazer JK; Sanger W; Anderson JR; Gross TG; Weinstein H; Harrison L; Shiramizu B; Barth M; Cairo MS
Br J Haematol; 2014 Nov; 167(3):394-401. PubMed ID: 25066629
[TBL] [Abstract][Full Text] [Related]
39. Palmar-plantar erythrodysesthesia (PPE): a literature review with commentary on experience in a cancer centre.
Webster-Gandy JD; How C; Harrold K
Eur J Oncol Nurs; 2007 Jul; 11(3):238-46. PubMed ID: 17350337
[TBL] [Abstract][Full Text] [Related]
40. Predisposing risk factors for palmar-plantar erythrodysesthesia when using liposomal doxorubicin to treat recurrent ovarian cancer.
Tanyi JL; Smith JA; Ramos L; Parker CL; Munsell MF; Wolf JK
Gynecol Oncol; 2009 Aug; 114(2):219-24. PubMed ID: 19446868
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]